Navigation Links
Neurologix Announces Second Quarter 2011 Financial Results
Date:8/11/2011

f operations after October 31, 2011 and to repay the promissory notes issued in December 2010 as of said date. Accordingly, there is substantial doubt as to the Company's ability to continue as a going concern. The Company is currently seeking to raise funds, through public or private equity offerings, debt financings or corporate collaboration and licensing arrangements, sufficient to finance its ongoing operations.  The Company does not know whether additional financing will be available when needed, or if available, will be on acceptable or favorable terms to it or its stockholders.
  • The Company will need to conduct future clinical trials for the treatment of Parkinson's disease using the Company's NLX technology. If the trials prove unsuccessful, future operations and the potential for profitability will be materially adversely affected and the business may not succeed.

    • Other factors and assumptions not identified above could also cause the actual results to differ materially from those set forth in the forward-looking statements. Additional information about factors that could cause results to differ materially from management's expectations is found in the section entitled "Risk Factors" in the Company's 2010 Annual Report on Form 10-K. Although the Company believes these assumptions are reasonable, no assurance can be given that they will prove correct. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results. Further, the Company undertakes no obligation to update forward-looking statements after the date they are made or to conform the statements to actual results or changes in the Company's expectations.

    Contact:Neurologix
    Marc Panoff, 201-592-6451
    Chief Financial Officer
    marcpanoff@neurologix.net'/>"/>

    SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinsons Disease at International Neuromodulation Society 10th World Congress
    2. Bion Announces New U.S. Patent for Phosphorus Removal
    3. ViaCyte Announces Executive Management Changes
    4. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
    5. Dendreon Announces Webcast Presentation at Canaccord Genuity Growth Conference
    6. Osteologix Announces Completion of Corporate Consolidation
    7. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results
    8. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
    9. Rigel Announces Second Quarter 2011 Financial Results
    10. WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.
    11. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/19/2013)... Bellevue, WA (PRWEB) June 19, 2013 ... open an exhibit hall of technology solutions for ... 6:30pm at the Hyatt Regency Bellevue. , ... to the public on Saturday and Sunday, will ... which includes power wheelchairs, communication devices, eyegaze technologies, ...
    (Date:6/19/2013)... ROCKVILLE, Md. , June 19, 2013 Synthetic ... on the prevention and treatment of serious infectious diseases, announced ... the 6 th Annual OneMedForum New York Conference on ... New York City . Mr. Riley is scheduled ... live webcast of Synthetic Biologics, presentation can be accessed by ...
    (Date:6/19/2013)... Today DuPont Executive Vice President James C. Borel ... greatest challenge facing our time – ensuring food security ... at the International Food and Agribusiness Management Association ... students to contribute their time and talents to create ... collaboration with others. , “Food is one of the ...
    (Date:6/19/2013)... (PRWEB) June 19, 2013 Applied Rigaku ... report that details the measurement of sulfur in ultra-low ... QC+ high resolution benchtop EDXRF analyzer . The analysis ... test method ISO 13032. This International Standard specifies ... the determination of sulfur content in automotive gasoline. , ...
    Breaking Biology Technology:City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2Synthetic Biologics to Present at OneMedForum New York 2013 2DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
    ... more hopeful promises of stem cells is the creation of new ... met by organ donation. But experts expressed concerns at last week's ... patients if cures do not materialize, and among investors if nobody ... way that stem cells could be used in the medical and ...
    ... A key lawmaker who often disagrees with Governor Jim ... saw nothing inappropriate about the governor's use of an executive ... cell companies. , ,Meanwhile, the executive order, signed Tuesday at ... the director of Pro Life Wisconsin. , ,Ted Kanavas, R-Brookfield, ...
    ... GE Healthcare has received federal approval for ... imaging for the estimated 20% of Americans that are considered ... from the Food and Drug Administration for its new wide ... therapy. The system is designed to meet growing demand for ...
    Cached Biology Technology:Stem cells raise hopes, but is there money in them? 2Stem cells raise hopes, but is there money in them? 3Republican sees nothing wrong with Doyle's use of executive order 2FDA okays new GE tomography system 2
    (Date:6/19/2013)... Tanzania is playing a vital role in the survival ... response to climate and environmental changes, according to new ... on savannah birds from the Tanzanian Bird Atlas project ... decades - the researchers found that they are using ... areas further west where dry seasons are getting longer, ...
    (Date:6/19/2013)... In the cover story for the journal Genetics ... the University of Massachusetts Amherst describe a new experimental ... the function of individual proteins in individual cell types ... allow deeper insights into protein function, Chase says, "because ... that single protein does when we isolate its function ...
    (Date:6/19/2013)... - The Flemish plant scientist Marc Van Montagu (born ... jointly with the American scientists Mary-Dell Chilton and Robert ... Wednesday by the US Secretary of State, John Kerry. ... food and agriculture" - gives the award annually to ... exceptional social importance for the quality, quantity or availability ...
    Breaking Biology News(10 mins):Protected areas provide African birds with stepping stones to survival 2UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4
    ... Stanford, CA A startling discovery by scientists at ... arguably the most important biological process on Earth. Photosynthesis ... living things by producing food from sunlight, and in ... dioxide. But two studies by Arthur Grossman and colleagues*+ ...
    ... discover why flamingos are so in the pink of health - ... Biology at the University of Leicester, has been studying lesser flamingos ... in the lakes of East Africa but new investigations he has ... own admission given him rather a shock. He said: ...
    ... Far from being a model of social co-operation, the ant ... goes all the way to the top, according to scientists ... always been thought to work together for the benefit of ... Hughes from Leeds Faculty of Biological Sciences has found evidence ...
    Cached Biology News:New twist on life's power source 2New twist on life's power source 3Scientists to discover why flamingos are in the pink of health -- in the poo! 2Royal corruption is rife in the ant world 2
    ... intensely fluorescent and highly photostable FluoSpheres ... in a variety of applications requiring ... signal. Unfortunately, protein- and other macromolecule-labeled ... cause them to bind to non-target ...
    DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
    ... Description: Proteinase K is a highly active ... of applications purified from the fungus T. album. ... group of N-substituted hydrophobic aliphatic and aromatic amino ... serine protease. Proteinase K is useful in purifying ...
    ...
    Biology Products: